发明名称 STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY
摘要 The invention provides methods for treating tumours, such as solid tumours, in a host. The methods may involve infecting the tumour with an amount of one or more strains of oncolytic virus. The virus will generally be selected to be effective to cause a lytic infection of tumour cells within the tumour. In various embodiments, the host neutrophil response to the lytic infection may be modulated, so that during the course of the lytic infection, the host has an initial neutrophil response and a secondary neutrophil response, these two responses being different in some material respect. For example, the secondary neutrophil response may mediate a greater degree of apoptotic killing of tumour cells than does the initial neutrophil response.
申请公布号 US2011044937(A1) 申请公布日期 2011.02.24
申请号 US20070375361 申请日期 2007.07.27
申请人 OTTAWA HEALTH RESEARCH INSTITUTE 发明人 BELL JOHN C.;BREITBACH CAROLINE JUDITH;ATKINS HARRY
分类号 A61K35/76;A61K38/19;A61K38/20;A61K38/21;A61K39/395;A61P35/00 主分类号 A61K35/76
代理机构 代理人
主权项
地址